Empery Asset Management, LP Medicenna Therapeutics Corp. Transaction History

Empery Asset Management, LP

  • $16.8 Million
  • Q3 2022

A detailed history of Empery Asset Management, LP transactions in Medicenna Therapeutics Corp. stock. As of the latest transaction made, Empery Asset Management, LP holds 589,316 shares of MDNA stock, worth $182,687. This represents 2.91% of its overall portfolio holdings.

Number of Shares
589,316
Holding current value
$182,687
% of portfolio
2.91%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.83 - $1.78 $489,132 - $1.05 Million
589,316 New
589,316 $489,000

Others Institutions Holding MDNA

# of Institutions
3
Shares Held
863K
Call Options Held
0
Put Options Held
0
View Full List

About Medicenna Therapeutics Corp.

MDNA Quotes by TradingView
  • Ticker MDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,637,504
  • Market Cap $21.6M
  • Description
  • Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...
More about MDNA
Track This Portfolio

Track Empery Asset Management, LP Portfolio

Follow Empery Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empery Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Empery Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email